Abstract:Several studies have demonstrated the efficacy of localized in situ transplantation of stem/progenitor cells for tissue/organ regeneration. However, the possible limitations of such an approach have largely been overlooked. This is contrary to the intrinsic physiological process of tissue/organ regeneration in vivo, which is thought to involve the mobilization of stem/progenitor cells resident within the tissue/organ itself, as well as from ectopic sites, in particular the bone marrow. Signaling pathways and other molecular processes within stem/progenitor cells transplanted in situ may not be primed to achieve optimal tissue/organ regeneration, and may even be confused by the sudden rapid transition in the cellular microenvironment encountered during transplantation. To overcome these putative limitations, a possible strategy may be to combine transfusion of stem/progenitor cells into the peripheral circulation with localized transplantation in situ at the site of tissue/organ damage. This could better replicate the natural physiological process of tissue/organ repair in vivo. Possible synergistic interactions between the transplanted stem/progenitor cells in situ with migratory transfused cells from the peripheral circulation may further enhance tissue/organ regeneration. The transfused stem/progenitor cells may be induced to home in on a damaged tissue/organ, via the controlled release of specific cytokines or chemokines (i.e., SDF-1) emanating from that particular tissue/organ. There are a number of possible ways to achieve this. For example, the transplanted cells may be delivered on tissue-engineered scaffolds that are designed for the controlled release of specific homing factors such as SDF-1. Another alternative may be to stimulate or genetically modulate the transplanted cells to copiously secrete homing factors such as SDF-1, to encourage the migration and homing of transfused cells within the peripheral circulation. At the same time, it may also be advantageous to pre-stimulate the transfused cells to strongly express surface receptors specific to homing factors such as SDF-1, in particular CXCR-4. More rigorous investigations should be carried out on the possible strategy of combining in situ transplantation of stem/progenitor cells with transfusion into the peripheral circulation, together with induced homing of the transfused cells to the site of organ/tissue damage. This may possibly result in better efficacy for some, but not all models of tissue/organ regeneration.

Homing of Human Hematopoietic Stem and Progenitor Cells: New Insights, New Challenges?

Combining Transfusion of Stem/progenitor Cells into the Peripheral Circulation with Localized Transplantation in Situ at the Site of Tissue/organ Damage: A Possible Strategy to Optimize the Efficacy of Stem Cell Transplantation Therapy

Progress Towards Improving Homing and Engraftment of Hematopoietic Stem Cells for Clinical Transplantation

Molecular Regulators of Chemotaxis in Human Hematopoietic Stem Cells

[Research Progress on Visual Observations of Hematopoietic Stem Cell Homing].

Homing and migration assays of hematopoietic stem/progenitor cells.

The Critical Role of Cell Homing in Cytotherapeutics and Regenerative Medicine

Irradiation Induces Homing of Donor Endothelial Progenitor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells

New Insights into Hematopoietic Stem Cell Expansion to Stimulate Repopulation of the Adult Blood System for Transplantation

Physiological Cues Involved in the Regulation of Adhesion Mechanisms in Hematopoietic Stem Cell Fate Decision

CCR2 cooperativity promotes hematopoietic stem cell homing to the bone marrow

Leveraging Stem Cell Homing for Therapeutic Regeneration

Hematopoietic Stem Cell Fates and the Cellular Hierarchy of Mammalian Hematopoiesis: from Transplantation Models to New Insights from in Situ Analyses

Stem cell engraftment strategies

Innate immunity as orchestrator of stem cell mobilization

Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells

Homing Efficiency and Hematopoietic Reconstitution of Bone Marrow-Derived Stroma Cells Expanded by Recombinant Human Macrophage-Colony Stimulating Factor in Vitro.

Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives.

The evolving hematopoietic niche during development

A Pre-Clinical Perspective